Clinical Trials
2,674 trialsBridge CRC
University of Illinois at Chicago
ASPIRES
Ann & Robert H Lurie Children's Hospital of Chicago
Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis
Minia University
Erector Spinae Plane Block in Laparoscopic Colorectal Cancer Surgery
Kayseri City Hospital
MK-4280A-007
Merck Sharp & Dohme LLC
X-CLOSURE
Islamabad Medical and Dental College
FORBES
Sun Yat-sen University
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
Emory University
Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy
BioNTech SE
PACE
UNC Lineberger Comprehensive Cancer Center
SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study
SafeHeal Inc
Evaluation of Colonic Perfusion by Indocyanine Green Angiography During Colorectal Surgery
University of Roma La Sapienza
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
POD Risk for Colorectal Cancer Surgery
LanZhou University
Phase IIT Trial of SNA009
SmartNuclide Biopharma
KITuKo
Medizinische Hochschule Brandenburg Theodor Fontane
SCORE
UNC Lineberger Comprehensive Cancer Center
Predicting Disease Progression and/or Recurrence in Cancer
Massachusetts General Hospital
IA COLO
University Hospital, Bordeaux
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
GRECCAR 5
University Hospital, Bordeaux
CIREL
Cardiovascular and Interventional Radiological Society of Europe
Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Cybrexa Therapeutics
Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT
University of California, San Diego
How Emotional Granularity Helps Build Resilience in Young and Middle-Aged Colorectal Cancer Survivors
The Hong Kong Polytechnic University
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
Genentech, Inc.
Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.
NantBioScience, Inc.
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
FHAMe
University of Toronto
COMPANION-003
Compass Therapeutics
LEAP-005
Merck Sharp & Dohme LLC
SH-SOC23
SafeHeal Inc
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
University of Wisconsin, Madison
SAFE2019
SafeHeal Inc
Clinicopathologic Features and Staging Risk Factors of Early-Onset Colorectal Cancer
Shenzhen Hospital of Southern Medical University
NAUTICALCRC
Pierre Fabre Medicament
Frailty Score and Postoperative Morbidity in Colorectal Cancer Surgery
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
HAIC,CRLM
West China Hospital
ICCE-Mito
University of Nottingham
NAVIGATE
Bayer
Physical Activity in Relation to Surgical Procedures
Sahlgrenska University Hospital
CodeBreak300
Amgen
Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer
Blokhin's Russian Cancer Research Center
CHALLENGE
Canadian Cancer Trials Group
Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
University of California, Irvine
Effectiveness of Using Mobile Health Technology in Colorectal Cancer Screening Uptake
Chinese University of Hong Kong
Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
ANICCA
University of Birmingham